New Delhi, 18/8:The Supreme Court was on Thursday told that the Central Board for Direct Taxes (CBDT) has accused makers of the Dolo-650 tablet of distributing freebies worth around Rs 1,000 crore to doctors as consideration for prescribing the tablet.
The drug has been used liberally during the Covid-19 pandemic.
Senior advocate Sanjay Parikh, representing Federation of Medical & Sales Representatives Association of India, contended before a bench presided over by Justice D Y Chandrachud that DOLO had invested Rs 1,000 core in freebies to have its anti-fever drug prescribed to patients.